SOFIA (Bulgaria), December 29 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said that its CEO Ognyan Donev acquired 19,400 shares in the company at a weighted average price of 3.18 levs ($1.99/1.63 euro) on December 23.